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Abstract: Epidemiological evidence suggests that pesticide exposure may be involved in the pathogenesis of 
Alzheimer’s disease (AD). However, whether maternal exposure to fenvalerate (FV) can affect AD-type behaviors in 
middle-aged offspring has not been determined yet. In this study, CD-1 mothers received 7.5 mg/kg FV or corn oil by 
gavage daily during gestational days 8–18. Body weight of the offspring was recorded at ages 4–34 weeks. A battery of 
behavioral tasks was conducted at 13-month, and 5-month-old mice were set as a young control. The results showed 
that there was insignificant difference in body weight between the FV-treated and control mice. Compared to the young 
mice, the middle-aged control mice exhibited decreased burrowing activity, decreased spontaneous exploration and 
sensorimotor ability, increased anxiety, and impaired abilities of spatial and non-spatial learning and memory. Compared 
to the controls, the FV-treated mice exhibited similar species-typical behaviors, locomotor activity, sensorimotor abilities, 
but increased anxiety, and decreased abilities of learning and memory. Our results suggested that chronically maternal 
exposure to FV at a low dose in medium-late gestation could accelerate the impairment in the behaviors of learning and 
memory and anxiety in the middle-aged offspring, which experience a normal duration of development.  
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1. INTRODUCTION  
With rapid expansion of old population, the 
incidence of dementia sharply increases, growingly 
becoming a serious burden to society. Alzheimer's 
disease (AD), the most common age-related dementia, 
has affected millions of people around the world [1]. 
Thus far, the etiology of AD remains unknown, especia- 
lly for sporadic AD, which accounts for over 95% of the 
total cases of AD. Increasing evidence indicates that 
AD could be the consequence of a multifactorial proce- 
ss, involving the interactions of gene-environment [2].  
Epidemiological evidence suggests that environme- 
ntal exposure, such as pesticide exposure, can impact 
the progression of AD-related symptoms and patholo- 
gies [3-6]. However, investigation of these effects in an 
epidemiological background is particularly difficult be- 
cause of the large time span between exposure and 
clinical manifestation of AD, as well as the uncontrolled 
nature of the exposures (such as number, type, and  
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frequency). By means of animal models, these 
difficulties could be resolved, and the changes of AD-
related behavior and neuropathology could be detected 
throughout the disease [7].  
Pesticides are world-widely used extensively in 
agriculture, farming, and other applications. Their acute 
toxic effects are well known, but the chronic and long-
term effects still remain uncertain [8]. A possible asso- 
ciation between chronic pesticide exposure and the 
increased prevalence of AD has lead to a considerable 
concern of the public health [8]. Pesticide exposure, 
even at very low doses, may cause neuronal dysfunc- 
tion, resulting in cognitive decline, including impaired 
memory and attention [9]. These neurobehavioral 
disturbances could eventually lead to AD in later life. 
However, little is known about how pesticide exposure 
might affect the pathogenesis of AD. Oxidative stress 
and mitochondrial dysfunction have been proved to be 
key mechanisms underlying AD induced by pesticide 
exposure [10,11]. A recent study indicated that pesti- 
cide exposure appears be associated with decreased 
the number of neurons in the hippocampus and cere- 
bral cortex, as well as memory-related synaptic 
proteins (including synaptophysin and synapsin I), and 
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induced tau hyperphosphorylation at multiple AD-
related phosphorylation sites, which could result in AD 
[12]. In recent years, it has been hypothesized that 
pesticide exposure can perturb AD-associated gene 
regulation (such as apolipoprotein E, amyloid precursor 
protein, or clusterin/apolipoprotein J genes) by epige- 
netic modification (i.e., DNA methylation and chromatin 
remodeling), leading ultimately to late-onset AD [13].  
Pyrethroid pesticides, the major class of insecti- 
cides, are commonly used in agriculture and in urban 
settings due to their high potency and selectivity as 
nerve poisons and their low amounts of persistent resi- 
dues. Fenvalerate (FV), a widely used pyrethroid insec- 
ticide, has been demonstrated to have behavioral 
disruptive effects in small rodents [14]. For example, 
chronic FV exposure in puberty could impair spatial 
cognition, inhibit aggressive behavior, and increase 
anxiety activity in mice [15]. Another study of acute 
exposure at very low-dose found that FV increased 
anxiety and immobility and decreased ambulation in 
adult mice, with sustainment of the effects for several 
hours [16]. These studies have mainly focused on the 
short-term effects of FV exposure on behaviors, with 
only few studies indicating that FV exposure may have 
long-term effects on behaviors [18, 19]. One study 
indicated that maternal exposure to FV in rats during 
lactation could decrease exploration ability and motor 
condition and increase anxiety, but did not affect life 
habits in pubertal offspring [17]. Another study indicat- 
ed that perinatal (from gestation day 18 to postnatal 
days 1–5) exposure to FV reduced sexual behaviors, 
but did not affect stereotypical and open-field behaviors 
in adult rats [18]. Nonetheless, the potential effects of 
chronic long-term FV exposure during early develop- 
ment on AD-type behaviors, especially cognitive func- 
tion, has not been investigated yet in the murine model.  
• The fetal period is one of critical period in early 
life, and it is characterized by high levels of 
epigenetic programming and imprinting, enabling 
disturbances to produce long-lasting effects [19]. 
Accumulating evidence indicates that most chronic 
diseases that are expressed in later life, such as 
AD, often find their origins in the fetal period [20]. 
Because the epigenome is much more susceptible 
to environmental factors during the fetal period 
than during later in life, it is important to avoid 
adverse environmental factors during this period to 
prevent adult disease [21]. 
• Accordingly, the present study aimed to explore 
whether chronic mother exposure to FV during 
medium-late pregnancy could alter age-related 
behavioral phenotypes in the middle-aged 
offspring mice. The dose of FV used, 7.5 mg/kg, 
was selected in previous experiments as a dose 
that did not induce overt signs of maternal toxicity 
or pup death. A battery of behavioral tests was 
used to comprehensively assess behavioral chan- 
ges in the present study, including the tasks of 
species-typical behavior, anxiety activity, sensori- 
motor, learning and memory.  
2. MATERIALS AND METHODS  
2.1. Animals and Treatments  
CD-1 mice (7–8 weeks old, 7 male and 7 female 
mice) were purchased from Vital River Laboratory 
Animal Technology Co. Ltd. (Beijing, China). The 
animals were maintained on a 12-h light-dark cycle in a 
control temperature (20–25°C) and humidity (50 ± 5 %) 
environment, with free access to food and water. After 
they acclimated to the room for one week, the males 
and females were paired into breeders. The presence 
of a vaginal plug was set as gestational day (GD) 0. 
The pregnant mice were randomly assigned to two 
groups. In the FV treatment group, the pregnant mice 
were administered FV (7.5 mg/kg, 3 mg/ml dissolved in 
corn oil, about 1/32 LD50 of FV) by gavage daily from 
GD 8–18. Pregnant mice treated with corn oil only were 
designated as controls. Natural birth occurred at GD 
18–19. On the postnatal day 21, the pups were 
separated from their mothers, and were housed 3–5 of 
the same sex in a plastic cage. The environment was 
the same as in the mother’s cage, and the offspring 
mice received a standard rodent diet and tap water ad 
libitum throughout all tasks and their lifetime.  
2.2. General Procedures  
One male and one female offspring mice per litter 
were measured for body weight with 7 males and 7 
females in each group. The body weight of each mouse 
was recorded at ages of 4, 6, 10, 14, 18, 22, 26, 30 and 
34 weeks. At age of 13 months, one male and one 
female offspring mice per litter were randomly selected 
to complete the behavioral tests. Meanwhile, 14 CD-1 
mice (7 males, 7 females) at age of 5 months old were 
set as a young control. The battery of tasks used in this 
study consisted of species-typical behaviors (hording, 
nesting and burrowing), anxiety behaviors (open field, 
elevated plus-maze and black-white alley), sensori- 
motor abilities (beam walking and tightrope), and 
learning and memory abilities (novel object recognition 
[NOR]) and radial six-arm water maze [RAWM]). The 
arranged sequence of these tests was: hording, nes- 
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ting, burrowing, open field, elevated plus maze, black-
white alley, beam walking, tightrope, NOR and RAWM. 
All tasks were performed in the feeding room. All 
animal experiments complied with the Guidelines for 
Animal Treatment set by the Committee of Laboratory 
Animal Sciences at the Anhui Medical University.  
2.3. Apparatuses and Behavioral Tests 
The apparatuses and procedures can be found in 
our previous description [22].  
2.3.1. Species-Typical-Behavior Tasks 
2.3.1.1. Hording 
A wire mesh tube with 60 cm long was attached to a 
testing box (30 cm  20 cm  15 cm), and 50 g of diet 
food pellets was placed at the far end of tube. Mice 
were singly housed in the box with wood shaving 
bedding before the start of the dark cycle, and they 
were free access to water. After an overnight, the food 
pellets found in the box were weighed and considered 
as the weight hoarded. 
2.3.1.2. Nesting  
Each mouse was housed in the cage with food, 
water and new sawdust bedding. Each cage was 
evenly placed with six pieces of white papery cloth (5 
cm  5 cm) for mice to build nests. In the next morning, 
the naturalistic scoring method was used to score each 
nest site from 0 to 4. No visible crater of sawdust and 
papery cloth received a score of 0; sawdust crater 
alone with no shredded cloth received a score of 1; 2 
scores were referred to sawdust crater with shredded 
or whole papery cloth gathered around and mixed in 
the crater; 3 was a cup-shaped nest; and 4 was a ball-
shaped nest covering the mouse.  
2.3.1.3. Burrowing  
A plastic cage, similar to the home cage, contained 
a plastic tube (4 cm in diameter, 10 cm long) and a 
bright iron tube (5 cm in radius, 12 cm long). Two bars 
(1 cm height) were transversely placed at the each end 
of floor in the iron tube, and the space between the 
bars was filled with exactly 40 g of maize. The mouse 
was released individually into the plastic cage, and 
after two hours the displaced contents from the tube 
was weighed. 
2.3.2. Anxiety-Based Tasks  
2.3.2.1. Open Field 
The open field was an open black wooden box (81 
cm  81 cm floor, and 28-cm wall height), and its floor 
was divided into 16 equal squares with white lines. A 
40-W white bulb was hung at the center of the field 
2.80 m above ground. Each mouse was introduced into 
a corner square, and permitted to explore the environ- 
ment for 5 min. The parameters recorded included time 
taken by the animal to cross the first square, number of 
squares crossed, and peripheral time (the time spent in 
the 12 peripheral squares). At the end of each test, the 
area was cleaned with water. 
2.3.2.2. Elevated Plus Maze 
Two opposite closed arms (30 cm  5 cm) enclosed 
with walls (height 15 cm) and two opposite open arms 
with the same size formed the black maze of cross 
shape, with a central arena (5 cm  5 cm). The cross 
maze was elevated to 80 cm above the ground. An 
animal was placed in the central arena facing an open 
arm. The number of entries into the open arms and the 
time spent on the open arms were recorded for 5 min 
during a single trial. The maze was thoroughly cleaned 
with water after each mouse was tested.  
2.3.2.3. Black-White Alley 
A box (120 cm  9 cm  30 cm) was made of 
narrow galvanized iron, and painted with one half black 
and the other half white, forming a long black-white 
alley. An animal was guided into the black half facing 
the wall. The latency to enter the white alley and the 
time spent in the black alley were recorded for 90 s.  
2.3.3. Sensorimotor Behaviors 
2.3.3.1. Beam Walking  
A steel rod (long 110 cm, diameter 1.0 cm) was 
attached to a platform (diameter 20 cm) each end, and 
was elevated 50 cm above the water surface in a black 
circular tank (diameter 150 cm). Mouse was placed 
perpendicularly on the center of the beam and given 
three successive trials. The maximum duration of the 
trial was set to 60 s. The balance time was recorded 
and averaged for the statistical analysis. 
2.3.3.2. Tightrope 
A cotton rope (2 mm in diameter) was stretched 
across a tank (100 cm in diameter) half-filled with 
water. Firstly, the animal was placed in the water for 5 
s. During a 60-s trial, each mouse was raised to grasp 
the center of the rope with forepaws, and then released 
slowly. Three successive trials on a single day were 
performed at 30 s intervals. The suspension time was 
averaged for the statistical analysis.  
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2.3.4. Cognitive Tasks  
2.3.4.1. NOR Test  
The Y-shaped apparatus had three equidistant 
arms, including a start arm (30 cm in length and 10 cm 
in width) and two object arms (23 cm long, 10 cm wide 
and 40 cm high), with painted black inside. There was 
a guillotine door in the start arm closed when mouse 
was exploring. The apparatus was placed in a sound-
proof room and rounded by a black cloth curtain. A 
video camera was positioned above the apparatus to 
record the activities of mice. A bulb provided a constant 
illumination of about 150 lx at the center of the 
apparatus.  
In the acclimation phase, the mice were habituated 
to the apparatus for 5 min per day for 3 days without 
objects. In the sample phase, the animal was placed 
into the Y-shape maze from the start arm with two 
identical objects in the object arms and allowed to 
explore for 5 min. After a 10-min or 24-h interval, the 
animal was allowed to explore the objects for 3 min (2 
choice phases), during which one of familiar objects 
used in the sample phase was replaced with a novel 
object. The apparatus and objects were cleaned with 
water at the end of each trial. The mice were regarded 
to be exploring when they directed their noses to the 
objects at less than 1 cm and/or touched it with their 
noses. The exploring-time for the familiar (TF) and the 
novel object (TN) during choice phase were recorded. 
The preferential index for novel object (PIN) in the 
choice phase was calculated as TN / (TF + TN)  100%. 
2.3.4.2. RAWM 
The apparatus was a black circular tank, with 100 
cm in diameter and 21 cm in height, and contained six 
swimming alleys radiating out from a 40-cm-diameter 
center area. One of the swimming alleys had a 
submerged escape platform (diameter 10 cm). The 
pool was filled with 20–21 °C water, and rounded by a 
white cloth curtain with three black cardboards of 
different shapes to guide the spatial navigation. The 
mice underwent five trials a day for 10 days. The 
location of the platform and experimenter were kept the 
same on each trial, but the sequences of starting points 
varied for each trial. On each trial, the mouse was 
allowed to swim for a maximum of 60 s to find the 
escape platform. Once locating the platform, the mouse 
was left there for 30 s prior to the next trial. The 
number of errors (entry into an incorrect arm) and the 
escape latencies (time before location on the platform) 
were recorded and averaged daily for data analysis. 
2.4. Statistical Analysis 
The data are presented as mean ± standard error of 
the mean (S.E.M.) for the parametric data or median 
(25th/75th quartile) for the nonparametric data. A one-
way analysis of variance (ANOVA) with treatment or 
age as an independent variable was used to analyze 
the normally distributed data, and the Mann-whitney U 
test was used to analyze non-normal distributed data. 
For the RAWM task and body weight, the repeated 
measures analysis of variance (rm-ANOVA) was used, 
with Fisher’s least significant difference test for post 
hoc analysis. All analyses were conducted with SPSS 
(13.0) software. Statistically significance was assumed 
when P<0.05.  
3. RESULTS 
3.1. Body Weight 
The rm-ANOVA results indicated that body weight 
was similar in the FV-treated and control mice for the 
combined sexes [F(1,26) = 0.516, P = 0.481], the males 
[F(1,12) = 1.628, P = 0.232], and the females [F(1,12) = 
1.712, P = 0.314], as summarized in Table 1.  
3.2. Species-Typical Behavior Tasks  
Only in burrowing was there a significant difference 
between the middle-aged control mice and the young 
mice, in terms of the weight burrowed [F(1,26) = 2.954, P 
= 0.007], with the middle-aged control mice burrowing 
less weight than the young ones. The “single-sex” 
ANOVAs indicated that this age difference in the weight 
burrowed mainly occurred in the males [F(1,12) = 2.567, 
P = 0.025]. There were no significant differences in the 
weight hoarded [X
2
(1,26) = 0.161, P = 0.872], weight 
burrowed [F(1,26) = 1.406, P = 0.172], and nesting 
quality [X
2
(1,26) = 0.380, P = 0.704] between the FV-
treated mice and the same-age controls. Further 
analysis indicated that FV exposure did not significantly 
affect the weight hoarded or burrowed or the nesting 
ability in either the males or the females (Ps > 0.05) 
(see Table 2).  
3.3. Anxiety-Based Tasks  
3.3.1. Open Field  
The middle-aged control mice spent significantly 
longer time in the periphery than the young mice when 
considering the combined sexes [X
2
(1,26) = 4.503, P < 
0.001], which was attributed to both the males and the 
females (Ps < 0.01). In addition, the middle-aged 
control females crossed less squares than the young 
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females [F(1,12) = 2.405, P = 0.033]. There were no 
significant differences in the peripheral time and the 
squares crossed between the FV group and the control 
group for the combined sexes [X
2
(1,26) = 0.184, P = 
0.854; F(1,26) = 0.608, P = 0.443], the males, and the 
females (Ps > 0.05). However, there was a significantly 
longer latency in the FV-treated mice than in the control 
ones [X
2
(1,26) = 2.344, P = 0.019], which was mainly 
attributed to the males [X
2
(1,12) = 2.108, P = 0.035] (see 
Table 2).  
3.3.2. Elevated Plus Maze  
The time spent on the open arm and the number of 
entries to the open arm were not significantly affected 
by age [F(1,26) = 0.737, P = 0.468; X
2
(1,26) = 0.542, P = 
0.588] or FV exposure [F(1,26) = 0.940, P = 0.356; X
2
(1,26) 
= 1.139, P = 0.255] for the combined sexes, the males 
or the females (Ps > 0.05) (see Table 2). 
3.3.3. Black-White Alley 
No significant effects of age or FV treatment were 
found on the latency to enter the white alley [X
2
(1,26) = 
0.276, 1.138; P = 0.783, 0.890] and the time spent in 
the black alley [X
2
(1,26) = 0.001, 1.287; P = 0.990, 0.198] 
for the combined sexes, the males or the females (Ps > 
0.05) (see Table 2).  
3.4. Sensorimotor Tasks  
In the beam-walking task, the middle-aged control 
mice had a significantly shorter balance time than the 
young ones in terms of the combined sexes [X
2
(1,26) = 
3.260, P = 0.001], males [X
2
(1,12) = 2.115, P = 0.034], 
and females [X
2
(1,12) = 2.606, P = 0.009]. However, FV 
treatment did not affect the balance time for the 
combined sexes [F(1,26) =1.333, P = 0.194], the males 
[F(1,12) = 1.197, P = 0.254], or the females [F(1,12) = 
0.457, P = 0.647]. In the tightrope task, there was a 
marginally significant age effect on the suspension time 
[F(1,26) = 2.032, P = 0.052], which was mainly attributed 
to the males [F(1,12) = 2.675, P = 0.020]. No significant 
FV treatment effect on suspension time was seen for 
the combined sexes [F(1,26) = 0.258, 2.032; P = 0.798, 
0.052], the males [F(1,12) = 1.247, P = 0.236], or the 
females [F(1,12) = 1.727, P = 0.110] (see Table 2).  
3.5. Cognitive Tasks  
3.5.1. NOR Test  
In the sample phase, the mice in the young control, 
middle-aged control and FV-treated group spent equal 
amounts of time exploring either of the two identical 
objects (data not shown), and thus there was no biased 
exploratory preference in the three groups of animals.  
In the 10-min- and 24-h-delay choice phase, the 
three group mice spent similar TN + TF exploring the 
two different objects (Ps > 0.05). The middle-aged 
control mice showed significantly lower PIN than the 
young mice, but significantly higher than the FV-treated 
mice for the combined sexes, the males and the 
females (Ps < 0.05) (see Table 3).  
3.5.2. RAWM  
3.5.2.1. Learning Phase 
Latency 
 Latency progressively decreased daily for all mice 
combined [F(9,351) = 52.323, Ps < 0.001; see Figure 1A], 
suggesting that the mice were able to learn this task. 
The rm-ANOVA results showed that the middle-aged 
control mice had significantly longer latencies than the 
Table 1: The Body Weights (g) of CD-1 Mice in the Different Ages with Maternal Fenvalerate Exposure 
Fenvalerate Control Age  
(weeks) 
Male (n=7) Female (n=7) Male (n=7) Female (n=7) 
4  20.1 ± 0.92 18.9 ± 0.59 18.9 ± 0.99 18.4 ± 0.73 
6  30.1 ± 0.74 24.9 ± 0.74 30.1 ± 0.78 24.8 ± 0.77 
10  34.8 ± 0.91 30.1 ± 0.79 36.1 ± 0.98 29.8 ± 0.76 
14  36.2 ± 1.05 33.8 ± 1.27 38.1 ± 1.04 33.3 ± 1.17 
18  38.2 ± 1.18 34.9 ± 1.72 41.7 ± 1.15 35.7 ± 1.23 
22  40.1 ± 1.45 35.9 ± 1.44 43.7 ± 1.45 36.7 ± 1.42 
26  41.8 ± 1.42 36.7 ± 1.88 44.2 ± 1.64 37.1 ± 1.87 
30  42.1 ± 1.62 36.9 ± 1.97 44.8 ± 1.78 37.9 ± 1.89 
34  42.9 ± 1.82 37.5 ± 1.78 45.2 ± 1.82 38.4 ± 1.82 
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young mice [F(1,26) = 9.709, P = 0.004; see Figure 1A], 
which was attributable to the females [F(1,12) = 8.158, P 
= 0.014; see Figure 1B]. In addition, the FV-treated 
mice showed significantly longer latencies than the 
same-age controls [F(1,26) = 13.54, P = 0.001; see 
Figure 1A], for both the males [F(1,12) = 5.548, P = 
0.036; see Figure 1C], and the females [F(1,12) = 10.263, 
P = 0.008; see Figure 1B].  
  
Table 2: The Performance of CD-1 Mice in Non-Cognitive Tasks 
Fevalerate Control Young Control 
Tasks Measure 
Total Males Females Total Males Females Total Males Females 
Hoarding Weight hoarded (g) 
3.6(0.5/ 
15.1) 
0.9(0.0/ 
11.9) 
3.8(1.5/ 
26.2) 
4.2(0.9/ 
6.2) 
2.4(0.0/ 
12.4) 
4.6(1.2/ 
5.3) 
4.3(2.3/ 
9.6) 
4.8(2.5/ 
9.6) 
3.4(1.1/ 
9.7) 
Burrowing Weight displaced (g) 2.0 ± 0.2 1.6±0.3 2.3±0.3 1.5 ± 0.2

 1.3±0.3

 1.7±0.3 2.6±0.3 2.4±0.3 2.8±0.5 
Nesting Nesting scores 
3.0 (1.7/ 
3.0) 
3.0(2.0/ 
3.0) 
2.0(1.0 / 
3.0) 
2.0(2.0/ 
3.0) 
2.0(2.0/ 
3.0) 
2.0(2.0/ 
3.0) 
2.5(0.7/ 
4.0) 
4.0(1.0/ 
4.0) 
1.0(0.0/ 
3.0) 
Latency (s) 
7.3(5.8/ 
11.3)

 
8.7(6.1/ 
11.9)

 
7.3(3.8/ 
8.9 
5.4(4.1/ 
6.3)

 
5.5(4.7/ 
6.4)

 
4.4(3.1/ 
6.0) 
6.0(2.6/ 
8.0) 
6.0(4.6/ 
8.0) 
3.0(2.0/ 
6.0) 
Peripheral time (s) 
268.0 
(254.0/ 
293.8) 
267.1 
(247.4/ 
297.5) 
269 
(256.2/ 
286.0) 
269.2

 
(253.8/ 
297.2) 
266.9

 
(254.8/ 
282.5) 
294.6

 
(250.8/ 
297.9) 
134.0 
(82.8/ 
160.5) 
92 
(82/ 
145.0) 
151.0 
(114.0/ 
165.0) 
Open-field 
Squares crossed  84.7± 11.1 78.6±16.7 90.8±15.4 94.8 ± 6.6 91.1±10.8 98.4±8.4

 118.7 ± 11.8 101.6±18.2 135.8±13.1 
Time on the open arm (s) 21.2 ± 6.5 24.8±9.2 17.6±9.8 30.1 ± 6.9 26.7±7.9 33.5±11.7 40.0 ± 11.4 40.0±14.4 40.0±19.0 
Elevated 
plus maze Number of entries to the 
open arms 
1.0(0.0/ 
2.0) 
1.0(0.0/ 
2.0) 
1.0(0.0/ 
2.0) 
2.0(0.7/ 
2.2) 
2.0(0.0/ 
2.0) 
1.0(1.0/ 
5.0) 
1.0(0.0/ 
4.0) 
2.0(0.0/ 
4.0) 
1.0(0.0/ 
2.0) 
Latency to enter the 
white alley 
14.3 
(11.8/24.9) 
23.5 
(12.2/41.5) 
13.4 
(8.4/15.1) 
14.6 
(12.2/22.9) 
14.1 
(12.8/22.9) 
14.8 
(10.6/23.2) 
15.0 
(8.5/21.5) 
19.0 
(15.0/24.0) 
9.0 
(6.0/14.0) Black–white 
alley 
Time spent in the black 
alley 
47.5 
(46.6/64.2) 
51.8 
(46.8/74.4) 
46.8 
(44.9/63.3) 
52.4 
(38.1/56.1) 
54.7 
(38.0/59.2) 
48.5 
(38.1/52.9) 
41.0 
(38.7/49.3) 
39.0 
(38.0/55.0) 
41.0 
(40.0/46.0) 
Beam 
walking 
Balance time (s) 
50.91 
(35.6/60.0) 
45.7 
(40.2/53.4) 
53.2 
(21.9/60.0) 
29.7
 
(11.4/60.0) 
28.8

 
(10.2/60.0) 
30.9

 
(16.8/60.0) 
60.0 
(60.0/60.0) 
60.0 
(51.0/60.0) 
60.0 
(60.0/60.0) 
Tightrope Suspension time (s) 32.0 ± 5.3 37.8±6.7 26.2±8.2 33.7± 4.2 26.0±6.6 41.5±3.4 44.8 ± 3.4 46.2±3.6 43.4±6.2 
*
Compared to the same aged control mice 

P<0.05 for the combined mice, and 

P<0.05 for the same sex; Compared to the young control mice 

P<0.05 for the 
combined mice, and 

P<0.05 for the same sex.  
 
Table 3: The Performance of CD-1 Mice in NOR Task 
10 min Delay 24 h Delay 
Groups 
TN+TF (s) PIN  TN+TF (s) PIN 
Total 12.43±0.81 0.56±0.051

 11.86±0.91 0.51±0.054

 
Male 13.16±0.79 0.58±0.054

 12.05±0.87 0.49±0.064

 FV 
Female 11.70±0.83 0.54±0.064

 11.67±0.93 0.53±0.058

 
Total 13.02±0.94 0.67±0.058

 12.41±0.82 0.63±0.051

 
Male 13.65±0.78 0.65±0.061

 13.12±0.96 0.65±0.054

 Control 
Female 12.39±0.92 0.69±0.055

 11.70±0.79 0.61±0.057

 
Total 13.98±1.09 0.79±0.065 13.04±0.67 0.73±0.081 
Male 14.10±0.96 0.77±0.063 13.67±0.82 0.75±0.065 
Young 
control 
Female 13.86±0.93 0.81±0.058 12.41±0.92 0.71±0.055 
*
Compared to the same aged control mice 

P<0.05 for the combined mice, and 

P<0.05 for the same sex; Compared to the young control mice 

P<0.05for the 
combined mice, and 

P<0.05 for the same sex. 
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Figure 1: Performances of fevalerate-treated, middle-aged control and the young mice in the RAWM. The latency (A, B and C) 
and number of errors (D, E and F) during the learning phase (trials 1-4), and the latency (G, H and I) and number of errors (J, K 
and L) during the memory phase (trial 5). There were significant age and treatment effects on all measures in the combined 
sexes, males and females during both the learning and memory phases, except for age effect on the latency and number of 
errors for the males during the learning phase. The sample number was 42 for the three groups with 14 in each per group. The 
bars standing represented for S.E.M. Compared to the same aged control mice 
#
P<0.05, and compared to the young control 
mice 
*
P<0.05.  
Errors 
The number of errors progressively decreased with 
days for all mice combined [F(9,351) = 42.319, P < 0.001; 
see Figure 1D]. Compared to the young mice, the 
middle-aged control mice displayed much number of 
errors [F(1,26) = 6.742, P = 0.015; see Figure 1D], for the 
females [F(1,12) = 4.941, P = 0.046; see Figure 1E], but 
not for the males [F(1,12) = 2.254, P = 0.159; see Figure 
1F]. The FV-treated mice had more number of errors 
than the middle-aged controls [F(1,26) = 8.059, P = 
0.009; see Figure 1D], for both the males [F(1,12) = 
4.933, P = 0.046; see Figure 1F] and the females 
[F(1,12) = 4.420, P = 0.039; see Figure 1E].  
3.5.2.2. Memory phase  
Latency 
Latency progressively also decreased over time 
[F(9,351) = 27.817, P < 0.001; see Figure 1G]. The rm-
ANOVA results showed that compared to the young 
mice, the middle-aged control mice showed signifi- 
cantly long latencies [F(1,26) = 18.171, P < 0.001; see 
Figure 1G], for both the males [F(1,12) = 6.755, P = 
0.023; see Figure 1I] and the females [F(1,12) = 13.253, 
P = 0.003; see Figure 1H]. Moreover, compared to the 
middle-aged controls, the FV-treated mice had 
significantly long latencies [F(1,26) = 12.142, P = 0.002; 
see Figure 1G], for both the males [F(1,12) = 6.823, P = 
0.023; see Figure 1I] and the females [F(1,12) = 4.791, P 
= 0.049; see Figure 1H].  
Errors 
The number of errors progressively decreased with 
days [F(9,351) = 25.729, P < 0.001; see Figure 1J]. The 
middle-aged control mice had more number of errors 
than the young mice [F(1,26) = 14.170, P = 0.001; see 
Figure 1J], for both the males [F(1,12) = 6.492, P = 
0.026; see Figure 1L] and the females [F(1,12) = 6.951,  
P = 0.022; see Figure 1K]. Moreover, the FV-treated 
mice had significantly more errors than the control mice 
[F(1,26) = 7.874, P = 0.009; see Figure 1J], for the males 
Chronically Maternal Exposure to Fenvalerate Journal of Advanced Neuroscience Research, 2014, Vol. 1, No. 1    35 
[F(1,12) = 4.801, P = 0.049; see Figure 1L] and the 
females [F(1,12) = 3.939, P = 0.032; see Figure 1K].  
4. DISCUSSION 
In the present study, our results indicated that there 
were similarities in body weight between the maternal 
FV-exposure and control CD-1 mice at different time 
points during the 34 weeks. Compared to the young 
mice, the middle-aged control mice exhibited 
decreased burrowing activity in the species-typical 
behavioral task, spontaneous exploration in the open 
field and sensorimotor ability in the beam-walking test, 
increased anxiety in the open field, and impaired 
abilities of spatial and non-spatial learning and memory 
in the RAWM and NOR tasks. Compared to the control 
mice, the FV-treated mice exhibited similar species-
typical behaviors in the hoarding, burrowing and 
nesting tasks, similar locomotors activity in the open 
field, similar sensor motor abilities in the beam-walking 
and tightrope tasks, but increased anxiety in the open 
field, and decreased learning and memory in the NOR 
(both the 10-min and 24-h delays) and RAWM tasks. 
These results suggested that the normal middle-aged 
CD-1 mice exhibited some behavioral changes, 
consisting of decreased species-typical behavior, 
spontaneous exploratory activity, and abilities of sensor 
motor, learning and memory, as well as increased 
anxiety. The middle-aged CD-1 mice, whose mothers 
were repeatedly exposed to FV at low doses during the 
embryo stage, exhibited normal growth development, 
but accelerated deterioration of learning and memory, 
and perhaps anxiety.  
Generally, there is a gradual decline in cognitive 
ability during normal aging, most markedly in certain 
types of memory, such as spatial, working, episodic, 
and long-term memory [23]. Spatial memory is often 
assessed in various mouse models of AD, because 
deficits in this type of memory are highly specific for 
hippocampal functions (one of the earliest/most 
severely affected brain regions in AD) [24]. One 
common method for assessing deficits in hippocampal-
based spatial memory is through the use of 
exploration-based memory tasks such as the Morris 
water maze and RAWM [25]. Our previous study 
demonstrated that RAWM was more sensitive for 
displaying mildly impaired abilities of spatial learning 
and memory than the Morris water maze task [22]. 
Another commonly tested type of AD-associated 
memory is recognition memory, and the most common 
way to assess this memory in mice is through the use 
of NOR task [25]. In many AD mouse models, it 
appears that deficits in spatial working memory (Morris 
water maze and RAWM) become apparent earlier than 
do deficits in NOR [26]. However, the onset age of 
memory impairment remains to be identified. 
Numerous studies have suggested that some aspects 
of age-related memory decline begin relatively early in 
adulthood [27].  
CD-1 mice, an outbred strain, are often used in 
transgenic research. They experience a high mortality 
rate, which is related to their high susceptibility to some 
immunopathologies and the high incidence of systemic 
amyloidosis [28]. Therefore, CD-1 mice may develop 
premature cognitive decline and could be useful as a 
model of aging. However, only a few studies have been 
devoted to age-related behavioral performance in CD-1 
mice. These studies indicated that middle-aged (12 
months old) CD-1 mice exhibited premature deficits in 
cognitive function measured in 3D. They also exhibited 
a great deal of anxiety in both non-social and social 
situations, spending less time in the open arms of the 
plus-maze and performing more freezing behavior in 
response to aggression [29-32]. In another study [33], 
CD-1 mice displayed decreased exploratory activity in 
a T-maze task as they aged. Our present study 
comprehensively evaluated behavioral changes in the 
middle-aged CD-1 mice, and found that they displayed 
decreased species-typical behaviors, spontaneously 
exploratory activity, and activities of sensorimotor, 
learning and memory, and increased anxiety, some of 
which (including exploratory activity, anxiety and 
cognitive function) were consistent with these previous 
studies [26-29]. These indicated the normal middle-
aged CD-1 mouse used in the present study was a 
qualified control.  
Increasing evidence supports the “fetal origins of 
adult disease” hypothesis, which holds that 
disadvantageous events during the fetal period increa- 
se the risk of later adult diseases, including coronary 
artery disease, hypertension, obesity, and insulin 
resistance, as well as degeneration diseases of the 
nervous system (such as AD) [2, 34]. Experimental 
evidence indicates that prenatal exposure to some 
pesticides causes long-term hormonal and behavioral 
alteration [32, 35, 36], which could eventually lead to 
AD. FV is particularly toxic to neurons, and it has been 
demonstrated to have endocrine disruptive effects [18]. 
A great deal of evidence indicates that endocrine 
disruption can affect cognitive, sexual, or anxiety-
related behaviors in humans and animals, especially 
during the critical period of development [37]. However, 
only few studies have been conducted to explore the 
effects of prenatal exposure to FV on the long-term 
behaviors, which mainly focusing on exploration, 
anxiety, and sexual behaviors [18, 19].  
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• In the present study, the pregnant CD-1 mothers 
were administrated 7.5 mg/kg of FV by gavage 
daily during gestation (GD 818). Maternal FV 
exposure did not cause fetal external anomalies or 
malformations. Moreover, maternal treatment with 
FV did not influence the physical development of 
the pups, i.e., no differences were observed in 
body weight when compared to the controls during 
adulthood. In addition, our battery of behavioral 
tests showed that compared to the same-age 
controls, there were no changes in species-typical 
behaviors, locomotor activity, or sensorimotor 
abilities in the FV-treated offspring at the age of 13 
months. Thus, we assumed that this pesticide had 
no toxic effects on general development during 
adulthood. Studies on laboratory rodents have 
indicated that pesticide exposure during 
development, even at low doses, can induce long-
term changes in anxiety-like behaviors. For 
instance, chronic perinatal exposure to low doses 
of chlorpyrifos led to an increase in anxiety-like 
behaviors in adult offspring of female mouse [38, 
39]. Our present study found that maternal 
exposure to FV could increase anxiety in middle-
aged offspring mice, according to the latency of the 
open field, a parameter clearly related to anxiety in 
this task. However, the FV-treated mice and the 
control mice showed similar anxiety levels in the 
elevated plus and black-white alley tests. This 
finding might suggest that the open field task could 
be more sensitive in assessing FV-treated anxiety 
than the other two tests.  
The acute effects of pyrethroids on learning and 
memory have been examined in a number of studies 
[14], but little evidence is available of their long-term 
effects on learning and memory. For instance, low-level 
exposure to deltamethrin in utero during GD 14-20 
decreased learning and memory performance in rats, 
and this change could persist even up to 12 weeks 
postnatal [34]. Low permethrin exposure from postnatal 
day 6 to 21 in rats impaired spatial working memory 
during late adulthood [37]. Mosquito repellent exposure 
during prenatal (GD 1-20) in rats could decrease 
learning and memory performance at the age of 
postnatal day 31 [36]. FV is a type-II pyrethroid, and to 
our knowledge, there have been no reports about the 
effects of chronic FV exposure in utero on learning and 
memory in adults. In this study, we simultaneously 
used NOR and RAWM tasks to assess whether non-
spatial and spatial learning and memory abilities were 
affected by maternal exposure to FV in middle-aged 
offspring of mice. In the NOR task, the middle-aged 
CD-1 mice exhibited impaired NOR after both 10-min 
and 24-h delays, and the FV treatment might aggravate 
this memory decline in the same tests. These results 
suggested that maternal exposure to FV declined 
hippocampus-dependent non-spatial memory in 
middle-aged offspring. For the RAWM task, our data 
showed that reduced performance was observed in the 
FV-treated offspring at 13 months when compared to 
the control mice of the same age, suggesting that an 
age-related decline in spatial learning and memory was 
accelerated by the maternal FV exposure during 
gestation.  
In summary, we reported that CD-1 offspring whose 
mothers received 7.5 mg/kg FV gavage daily during 
GD 8–18 showed a relatively normal duration of 
development, but they displayed accelerated the 
impairment in hippocampus-dependent learning and 
memory (spatial and non-spatial) and perhaps anxiety 
in the middle age. These results meet the behavioral 
criteria of AD. Further research is needed to explore 
the underlying mechanism by which FV influences 
these behavioral changes.  
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